Coalesce Capital has announced its acquisition of DAS Health Ventures.
DAS Health, founded in 2003 and headquartered Tampa, Florida, is a provider of healthcare IT and business solutions to independent and enterprise physician groups and healthcare systems across North America.
Coalesce, founded in 2022 and based in New York, is a middle market private equity firm focused on investing in human capital and technology-enabled business services companies. The firm primarily makes control investments in companies with at least $5 million of EBITDA and $25 million of revenue.
Sheridan Capital Partners, which invested in DAS Health in 2021, will retain a minority ownership position.
Terms of Coalesce’s acquisition were not disclosed.
